Validation of HPV triage in cytology-based cervical cancer screening for ASC-US cases using Japanese data.
Eiko Saitoh AokiKumiko SaikaKazushige KiguchiTohru MorisadaDaisuke AokiPublished in: Journal of gynecologic oncology (2022)
cases was sufficiently low, compared with that of the NILM cases, we considered it reasonable and safe to perform HPV triage for ASC-US cases and to allow HPV-negative cases to return for their next screening in 2 years, which is the same follow-up schedule as that for NILM cases.